Navigation Links
Tracking down the origin of leukemia relapse
Date:4/4/2011

The cancer cells that reign during relapses of an aggressive human leukemia are different from those that dominated the original disease, according to a paper published online on April 4 in the Journal of Experimental Medicine (www.jem.org).

By comparing the DNA of cancer cells taken at the time of diagnosis and relapse from patients with T cell acute lymphoblastic leukemia (T-ALL), Jean Soulier and co-workers found that the relapse cells arose from cells that were scarce at the time of diagnosis. The relapse cells had also picked up several new and dangerous mutations. Mimicking these mutations in cells isolated at diagnosis rendered them more cancerous after injection into immune-depleted mice.

Untouched cancer cells from diagnosis samples also caused leukemia when injected into mice. And once established, they bore a closer genetic resemblance to relapse cells than to their former selves, suggesting that the most aggressive cancer cells prevail in both mouse and man.

These findings suggest that tracking human leukemia development in immune-depleted mice might provide insight into the mechanisms underlying relapses of the human disease.


'/>"/>

Contact: Rita Sullivan
news@rupress.org
212-327-8603
Rockefeller University Press
Source:Eurekalert

Page: 1

Related medicine news :

1. Tracking down particulates
2. Tracking PSA Test Results Over Time Gives Clues to Cancer
3. Color-coded tracking method helps scientists analyze outcomes of newly transplanted tissue
4. Life Science Contract Manufacturing Gains Predictable On-Time Production with TraceLink's Production Tracking Solution
5. USPack Courier Brings Tracking Precision to Medical and Blood Shipments
6. Newest Release of FileTrail Sets New Standard in Global Physical Records Management and File Tracking
7. TalentWise Integrates Employment Screening with Leading Applicant Tracking Solution for Healthcare Industry TalentWise becomes HealthcareSource Certified Integration Partner For Position Manager Product
8. COO Becomes 75% More Effective in Tracking Delegated Tasks
9. Tickerspy.com Announces New Stock Index Tracking Chinese Healthcare Stocks
10. Massive Food Flavoring Recall Underscores Need for New Tracking Technology to Contain Outbreaks of Foodborne Illness
11. The Pediatric Dengue Vaccine Initiative Introduces www.DengueWatch.org - a News hub for Tracking Dengue Fever Epidemics Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The Dan Carlisle Agency, ... Jefferson County, is announcing the launch of a charity drive to raise support ... homeless women and children in Birmingham has grown steadily since the 1980’s, and ...
(Date:12/8/2016)... Wichita, KS (PRWEB) , ... December 08, 2016 ... ... and financial consultation services to families and business owners in and around central ... to provide assistance to at-risk youth in the region. , Headquartered in Wichita, ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... in their bodies, a researcher at the Icahn School of Medicine at Mount ... The study found that when young children are exposed to secondhand marijuana smoke, ...
(Date:12/7/2016)... ... December 07, 2016 , ... In the early morning ... to an emergency medical call when he lost control of his patrol car. The ... from his vehicle, he was transported to Atlanta Medical Center, where he later succumbed ...
(Date:12/7/2016)... MA (PRWEB) , ... December 07, 2016 , ... They ... They are sisters and wives, brothers and fathers, from New England and around the ... and its stigma, and are brought together in a beautiful and compelling new photographic ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... 7, 2016 Hoovers Research analysis ... using the combinational analytical tools. The report contains ... research sources to present unique and reliable analysis. ... the market during the next five years, including ... comprises of sub markets, regional and country level ...
(Date:12/7/2016)...   Arena Pharmaceuticals, Inc. (NASDAQ: ... in the ralinepag phase 2 trial.  Ralinepag is an ... for the treatment of pulmonary arterial hypertension (PAH). The ... "This marks an important step in the development ... on our pipeline," said Amit Munshi , Arena,s ...
(Date:12/7/2016)... , Dec. 7, 2016 Diplomat Pharmacy, Inc. (NYSE: DPLO) ... subsidiaries—American Homecare Federation, At-Home IV Infusion Professional, BioRx, MedPro Rx, and ... infusion services, visit diplomat.is/specialty-infusion .  ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, ... "As we continue to build on ...
Breaking Medicine Technology: